Publication | Closed Access

PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

MedicinePten Gene ExpressionImmunologyPik3ca GenePathologyColorectal CancerClinical BenefitCancer GeneticsOncology